Rchr
J-GLOBAL ID:200901030984151599   Update date: Oct. 31, 2024

Baba Eishi

ババ エイシ | Baba Eishi
Affiliation and department:
Job title: Professor
Research field  (2): Gastroenterology ,  Gastroenterology
Research keywords  (4): 腫瘍免疫学 ,  臨床腫瘍学 ,  Tumor Immunology ,  Clinical oncology
Research theme for competitive and other funds  (27):
  • 2022 - 2025 Biosensor based on surface molecular information of extracellular vesicles
  • 2021 - 2024 超高感度細胞膜抗原検出法の開発とがんコンパニオン診断への応用
  • 2020 - 2022 消化器腫瘍三次リンパ組織様構造TLSの構成細胞に基づく予後予測と耐性機序の探索
  • 2018 - 2021 Ultra-sensitive detection method of membrane antigens and its application to cancer companion diagnosis
  • 2015 - 2017 Molecular mechanisms of differentiation and metastasis of human gastrointestinal cancer stem cells
Show all
Papers (251):
  • Kenro Tanoue, Hirofumi Ohmura, Koki Uehara, Mamoru Ito, Kyoko Yamaguchi, Kenji Tsuchihashi, Yudai Shinohara, Peng Lu, Shingo Tamura, Hozumi Shimokawa, et al. Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer. Nature communications. 2024. 15. 1. 9033-9033
  • Kanami Furukawa, Hirofumi Ohmura, Shohei Moriyama, Koki Uehara, Mamoru Ito, Kenji Tsuchihashi, Taichi Isobe, Hiroshi Ariyama, Mitsuhiro Fukata, Hitoshi Kusaba, et al. Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study. Japanese journal of clinical oncology. 2024
  • Yuho Najima, Tomoya Maeda, Yutaro Kamiyama, Shinji Nakao, Yukinori Ozaki, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Yuji Miumra, Makoto Endo, et al. Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology. International journal of clinical oncology. 2024
  • Kenji Tsuchihashi, Mamoru Ito, Yuta Okumura, Kenta Nio, Yukinori Ozaki, Hiroshi Nishio, Eiki Ichihara, Yuji Miura, Makoto Endo, Shingo Yano, et al. Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology. International journal of clinical oncology. 2024
  • Tomoya Maeda, Yuho Najima, Yutaro Kamiyama, Shinji Nakao, Yukinori Ozaki, Hiroshi Nishio, Kenji Tsuchihashi, Eiki Ichihara, Yuji Miumra, Makoto Endo, et al. Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology. International journal of clinical oncology. 2024. 29. 5. 535-544
more...
MISC (103):
  • 田口綾祐, 磯部大地, 上野翔平, 菊繁吉謙, 土橋賢司, 有山寛, 赤司浩一, 馬場英司. DNMT3B maintains the organoid-formation ability of left-sided colorectal cancer derived from patients. 日本癌学会学術総会抄録集(Web). 2022. 81st
  • 田ノ上絢郎, 大村洋文, 山口享子, 土橋賢司, 田村真吾, 磯部大地, 有山寛, 江崎泰斗, 赤司浩一, 馬場英司. Circulating stem-like PD-1+ CD8 T cells responding to PD-1 blockade predict clinical outcomes in esophageal cancer. 日本癌学会学術総会抄録集(Web). 2022. 81st
  • 上野翔平, 磯部大地, 田口綾祐, 土橋賢司, 有山寛, 赤司浩一, 馬場英司. The amplification of TPX2 is a potential biomarker of oxaliplatin-susceptibility in colorectal cancer. 日本癌学会学術総会抄録集(Web). 2022. 81st
  • 田ノ上絢郎, 大村洋文, 土橋賢司, 篠原雄大, 伊東守, 山口享子, 田村真吾, 下川穂積, 磯部大地, 柴田義宏, et al. ニボルマブ治療を受けた切除不能進行食道癌患者における末梢血中の疲弊細胞の意義. 日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集. 2022. 119th-113th
  • 草野亘, 土橋賢司, 田口綾祐, 吉弘知恭, 古川佳那美, 大村洋文, 伊東守, 磯部大地, 有山寛, 草場仁志, et al. A case of gastric cancer with bone marrow metastasis surviving for more than 4 years after 3-weekly S-1+CDDP therapy. 日本臨床腫瘍学会学術集会(CD-ROM). 2022. 19th
more...
Books (1):
  • Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer
    2019
Lectures and oral presentations  (71):
  • The Update of Japanese gastric cancer guidelines: Chemotherapy for unresectable advanced/recurrent gastric cancer in the 6th edition (2021)
    (Chinese Society of Clinical Oncology, Gastrointestinal Cancer Immunotherapy Forum 2021 2021)
  • MSI-High固形癌の新たな治療戦略
    (第78回日本癌学会学術総会 2019)
  • Single-cell transcriptomics identifies RHAMM positive proliferative cells within human colorectal cancer stem cells
    (Keystone Symposia 2019)
  • Classification of BRAF mutated colorectal cancer based on microsatellite stability
    (Gastrointestinal Cancers Symposium 2019)
  • 無症候性の重症冠攣縮性狭心症を呈したフルオロウラシル投与患者
    (第1回腫瘍循環器学会総会 2018)
more...
Professional career (1):
  • (BLANK) (Kyushu University)
Work history (2):
  • 2019/03 - 現在 Faculty of Medical Sciences, Kyushu University Department of Oncology and Social Medicine Graduate School of Medical Sciences Professor
  • 2017/08 - 2019/02 Faculty of Medical Sciences, Kyushu University Department of Comprehensive Clinical Oncology Professor
Committee career (23):
  • 2021/04 - 現在 九州大学病院 がんセンター センター長
  • 2020/12 - 現在 九州大学病院 希少がんセンター センター長
  • 2020/04 - 現在 日本胃癌学会 ガイドライン作成委員会委員長
  • 2018/01 - 現在 日本胃癌学会 代議員
  • 2015 - 現在 日本癌治療学会 代議員
Show all
Association Membership(s) (17):
日本胃癌学会 ,  European Society of Medical Oncology ,  American society of clinical oncology ,  Japan Gastroenterological Endoscopy Society ,  American Association of Immunologist ,  Japan Society of Clinical Oncology ,  THE JAPANESE SOCIETY OF GASTROENTEROLOGY ,  Japanese Society for Immunology ,  Japanese Society of Medical Oncology ,  Japanese Cancer Association ,  The Japanese Society of Internal Medicine ,  The Japan Esophageal Society ,  American Society of Clinical Oncology ,  The Japanese Association for Molecular Target Therapy of Cancer ,  Japanese Association for Supportive Care in Cancer ,  European Society for Medical Oncology ,  The Japanese Onco-Cardiology Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page